Your browser doesn't support javascript.
loading
Automatic quality control in clinical (1)H MRSI of brain cancer.
Pedrosa de Barros, Nuno; McKinley, Richard; Knecht, Urspeter; Wiest, Roland; Slotboom, Johannes.
Affiliation
  • Pedrosa de Barros N; University Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging (SCAN), University Hospital Bern (Inselspital), Bern, Switzerland.
  • McKinley R; University Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging (SCAN), University Hospital Bern (Inselspital), Bern, Switzerland.
  • Knecht U; University Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging (SCAN), University Hospital Bern (Inselspital), Bern, Switzerland.
  • Wiest R; University Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging (SCAN), University Hospital Bern (Inselspital), Bern, Switzerland.
  • Slotboom J; University Institute for Diagnostic and Interventional Neuroradiology, Support Center for Advanced Neuroimaging (SCAN), University Hospital Bern (Inselspital), Bern, Switzerland.
NMR Biomed ; 29(5): 563-75, 2016 May.
Article de En | MEDLINE | ID: mdl-27071355
ABSTRACT
MRSI grids frequently show spectra with poor quality, mainly because of the high sensitivity of MRS to field inhomogeneities. These poor quality spectra are prone to quantification and/or interpretation errors that can have a significant impact on the clinical use of spectroscopic data. Therefore, quality control of the spectra should always precede their clinical use. When performed manually, quality assessment of MRSI spectra is not only a tedious and time-consuming task, but is also affected by human subjectivity. Consequently, automatic, fast and reliable methods for spectral quality assessment are of utmost interest. In this article, we present a new random forest-based method for automatic quality assessment of (1)H MRSI brain spectra, which uses a new set of MRS signal features. The random forest classifier was trained on spectra from 40 MRSI grids that were classified as acceptable or non-acceptable by two expert spectroscopists. To account for the effects of intra-rater reliability, each spectrum was rated for quality three times by each rater. The automatic method classified these spectra with an area under the curve (AUC) of 0.976. Furthermore, in the subset of spectra containing only the cases that were classified every time in the same way by the spectroscopists, an AUC of 0.998 was obtained. Feature importance for the classification was also evaluated. Frequency domain skewness and kurtosis, as well as time domain signal-to-noise ratios (SNRs) in the ranges 50-75 ms and 75-100 ms, were the most important features. Given that the method is able to assess a whole MRSI grid faster than a spectroscopist (approximately 3 s versus approximately 3 min), and without loss of accuracy (agreement between classifier trained with just one session and any of the other labelling sessions, 89.88%; agreement between any two labelling sessions, 89.03%), the authors suggest its implementation in the clinical routine. The method presented in this article was implemented in jMRUI's SpectrIm plugin.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Contrôle de qualité / Tumeurs du cerveau / Imagerie par résonance magnétique / Spectroscopie par résonance magnétique du proton Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: NMR Biomed Sujet du journal: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Année: 2016 Type de document: Article Pays d'affiliation: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Contrôle de qualité / Tumeurs du cerveau / Imagerie par résonance magnétique / Spectroscopie par résonance magnétique du proton Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: NMR Biomed Sujet du journal: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Année: 2016 Type de document: Article Pays d'affiliation: Suisse